MF
STLN

Magnetar Financial’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Magnetar Financial’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-913,355
Closed -$9.06M – 1554
2021
Q3 		$9.06M Buy
913,355
+2,462
+0.3% +$24.4K 0.09% 230
2021
Q2 		$9.05K Hold
910,893
– – 0.09% 227
2021
Q1 		$9.07M Buy
910,893
+14,547
+2% +$155K 0.09% 213
2020
Q4 		$9.68M Buy
+896,346
New +$9.23M 0.14% 166

Other funds holding STLN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Triatomic Management Palo Alto, California $3.39M AUM 3.35% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Magnetar Financial's STLN Position: Q4 2021 in Review

Magnetar Financial sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q4 2021, closing a stake of 913,355 shares — an estimated $9.06M sold.

Magnetar Financial first reported a position in STLN in Q4 2020 and held it in 4 quarters. The position peaked at $9.68M in Q4 2020. 21 funds tracked by Wall St. Rank hold STLN as of Q4 2021.

  • Magnetar Financial reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Magnetar Financial sold 913,355 Starling Oncology Institute, Inc. Common Stock shares in Q4 2021, an estimated $9.06M.
  • Magnetar Financial first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • Magnetar Financial's Starling Oncology Institute, Inc. Common Stock position peaked at $9.68M in Q4 2020.
  • 21 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q4 2021.

Based on Magnetar Financial's 13F filing for Q4 2021, filed 14 Feb 2022.